OXLEY, BRENT – Trademark Portfolio
Entity Type: 01
OXLEY, BRENT has 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include RX.COM. The portfolio includes 1 registered trademark. Filings span 5 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 44 (Medical Services). This trademark owner is based in UVALDE, TX.
1946 PRIVATE ROAD 2485
UVALDE, TX 78801
Showing of trademarks Trademarks
Trademark Classifications
OXLEY, BRENT's trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does OXLEY, BRENT have?
OXLEY, BRENT has 11 U.S. trademarks filed with the USPTO. Of these, 1 registered, 10 cancelled.
What trademark classes does OXLEY, BRENT file in?
OXLEY, BRENT files trademarks across 5 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services), Class 42 (Computer & Scientific), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.
What are OXLEY, BRENT's most well-known trademarks?
OXLEY, BRENT's registered trademark portfolio includes well-known marks such as RX.COM. These are among 1 currently registered trademark in the portfolio.
What is OXLEY, BRENT's trademark registration success rate?
OXLEY, BRENT has a 9% trademark registration rate, with 1 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.